In HER3/MET‐dKO SW1116 cells, in vitro cell proliferation and in vivo tumor growth were significantly inhibited and G0/G1 arrest was induced, indicating that simultaneous HER3/MET targeting was effective (Figure 4B–F). This evidence concerns the gene ERBB3 and neoplasm.